Pulmonary embolism (PE) affects many, with an estimated incidence of up to 69 cases per 100,000 persons annually. In the U.S., 101,000 patients were hospitalized with a primary diagnosis of PE in 2002, resulting in direct medical costs of $720 million. Outpatient treatment with low-molecular-weight heparin (LMWH) may be an effective and safe option for up to 50% of patients with non-massive PE. Despite this evidence, outpatient treatment of PE is extremely rare because (1) explicit criteria that identify patients who are at low-risk of adverse medical outcomes were not available until recently, and (2) limited data defining the safety and effectiveness exists. We previously developed a clinical prognostic model that accurately identifies patients with PE who are at low-risk for short-term mortality, symptomatic recurrent PE (primary outcome) or venous thromboembolism (VTE) and major bleeding (secondary outcomes). The broad objective of this clinical trial is to address the other major barrier to outpatient treatment of low-risk patients with non-massive PE, the effectiveness and safety of outpatient management. We will randomize 320 low-risk patients (identified using our prognostic model) with PE from 10 hospital emergency departments in the U.S. and Western Europe to receive outpatient or inpatient treatment with LMWH for =5 days, followed by oral anticoagulation.
The specific aims of the project are to compare (1) the frequency of re-current PE, (2) the frequency of recurrent VTE, major bleeding and all-cause mortality, and (3) medical resource utilization and patient satisfaction with care among patients randomized to receive outpatient or inpatient treatment with LMWH. The study outcomes and all cause mortality will be assessed at 3 months. We hypothesize that out-patient treatment with LMWH is as effective and safe as inpatient treatment with LMWH, and is associated with reduced medical resource utilization and increase patient satisfaction with care. Our innovative design translates a validated prognostic model into clinical practice and addresses a key barrier to effective, less costly care of select patients with PE.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Project (R01)
Project #
5R01HL085565-02
Application #
7911783
Study Section
Clinical Trials Review Committee (CLTR)
Program Officer
Moore, Timothy M
Project Start
2009-07-01
Project End
2012-06-30
Budget Start
2010-07-01
Budget End
2012-06-30
Support Year
2
Fiscal Year
2010
Total Cost
$349,378
Indirect Cost
Name
University of Pittsburgh
Department
Emergency Medicine
Type
Schools of Medicine
DUNS #
004514360
City
Pittsburgh
State
PA
Country
United States
Zip Code
15213
Stuck, Anna K; Stone, Roslyn A; Pugh, Nathan et al. (2014) Comparison of the Pulmonary Embolism Severity Index to a simplified version: classification and clinical outcomes. Thromb Res 133:515-6
Seymour, Christopher W; Rea, Thomas D; Kahn, Jeremy M et al. (2012) Severe sepsis in pre-hospital emergency care: analysis of incidence, care, and outcome. Am J Respir Crit Care Med 186:1264-71
Vinson, David R; Zehtabchi, Shahriar; Yealy, Donald M (2012) Can selected patients with newly diagnosed pulmonary embolism be safely treated without hospitalization? A systematic review. Ann Emerg Med 60:651-662.e4
Weaver, Matthew D; Moore, Charity G; Patterson, P Daniel et al. (2012) Medical necessity in emergency medical services transports. Am J Med Qual 27:250-5
Aujesky, Drahomir; Roy, Pierre-Marie; Verschuren, Franck et al. (2011) Outpatient versus inpatient treatment for patients with acute pulmonary embolism: an international, open-label, randomised, non-inferiority trial. Lancet 378:41-8
Mitchell, Alice M; Kline, Jeffrey A (2010) Save the beans. Ann Emerg Med 56:62-3